4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK),
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific nitrosamine, induces lung adenomas in A/J mice within months after a single intraperitoneal (ip) injection (Hecht et al., 1989) . The initial event in NNK-induced lung tumorigenesis is the formation of O 6 -methylguanine (O 6 MeG), a major promutagenic adduct which leads to GC3 AT transitional mispairing and an activation of the K-ras proto-oncogene in the A/J mouse lung (Peterson and Hecht, 1991; Ronai et al., 1993) . Formation of O 6 MeG from NNK is believed to result from ␣-hydroxylation of the methlylene group adjacent to the N-nitroso nitrogen by cytochrome P 450 enzymes (Hoffmann et al., 1994) (Fig. 1) .
Although ip injections of NNK (2.5 to 10 mole/mouse) have been shown to induce lung adenomas in A/J mice (Hecht et al., 1989) , inhalation of cigarette smoke has not induced or promoted tumors in this mouse model (Finch et al., 1996) . Numerous studies have demonstrated that nicotine can inhibit the metabolic activation of NNK both in vitro (Murphy and Heiblum, 1990; Schuller et al., 1991) and in vivo (Richter and Tricker, 1994) . In a study using snuff, snuff extract, and tobacco-specific nitrosamines (TSNA) to evaluate the induction of oral-cavity tumors in rats, the authors hypothesized the possibility of nicotine acting as a competitive inhibitor of the metabolic activation of the TSNA in snuff (Hecht et al., 1986) . Moreover, studies from our laboratory have shown that nicotine, its major metabolite cotinine, and aqueous solutions of cigarette tar all effectively reduce the genotoxicity of NNK in both Ames mutagenicity and sister chromatid exchange assays . Cigarette smoke is a complex mixture containing thousands of components, some of which are recognized as either substrates or competitive inhibitors of the cytochrome P 450 enzymes (Murphy and Heiblum, 1990) . The evidence suggests that competitive inhibition of cytochromes P 450 by nicotine, cotinine and/or other tobacco constituents is the most likely mechanism for their observed modulation of the biological effects of NNK Murphy and Heiblum, 1990) .
High-performance liquid chromatography (HPLC), with a strong cation-exchange column coupled with absorbance and fluorescence detection, is the method of choice for the quantification of methylated DNA adducts produced by NNK (Bedell et al., 1982; Hecht et al., 1986b; Herron and Shank, 1979) . We previously optimized sample preparation and detection conditions in our HPLC systems for NNK-induced, methylated adducts (Chang et al., 1996 (Chang et al., , 1998 , and we have applied those optimized methods. Concentrations of lung and liver O 6 MeG adducts increase rapidly during the first 2 h after the ip administration of NNK, plateau at 4 h and remain relatively stable for at least 24 h (Chang et al., 1998) . The objective of this study was to evaluate the effects of cotinine or CS on the formation of promutagenic O 6 MeG adducts in A/J mice during the acute phase of NNK treatment.
MATERIALS AND METHODS

Chemicals
NNK was purchased from Chemsyn Science Laboratories (Lenexa, KS). Guanine (Gua), O 6 MeG and cotinine were purchased from Sigma Co. (St. Louis, MO); the latter was redistilled to reach a purity greater than 99% as determined by gas chromatography. 1R4F reference cigarettes were purchased from the Tobacco and Health Institute of the University of Kentucky (Lexington, KY) and were stored at 4°C until use. The cigarettes were unpacked and conditioned for 24 -72 h in a Climate-Lab @ cabinet (PGC, Black Mountain, NC) at a 40 -70% relative humidity and a temperature of 18 -26°C prior to smoking.
Inhalation Exposure System
Smoke generator. Mainstream smoke from 1R4F reference cigarettes was generated using a 30-port, computer-controlled smoke generator (Ayres et al., 1990) with automatic load and ejection capabilities. Mainstream smoke was generated using the Federal Trade Commission (FTC) puffing regimen of a 2-s puff with 35 ml volume, and a frequency of one puff per min. Puff volume was measured with a soap bubble flow meter before the inhalation exposure, and a peristaltic pump was used to create the vacuum for the puff. Nose-only exposure chamber. The nose-only exposure chamber consisted of three circular tiers with 24 exposure ports per tier. The flow rate passing through the nose-only exposure chamber was adjusted to 25 L/min to provide approximately 300 ml/min/port of air at each exposure port. Before smoke exposures were initiated, performance of the nose-only smoke exposure was evaluated to confirm that the coefficients of variance for the average air flow rate within a tier, flow rate among tiers, temporal stability and between-port variability were 3%, 2%, 1%, and 2%, respectively.
Exposure concentration and duration. The concentration of smoke in the nose-only exposure chamber was controlled by a feedback-loop exposure controller. Breathing zone smoke concentrations were monitored by a RAM-1 aerosol concentration analyzer (MIE Corp., Billerica, MA). The analog signal from a RAM-1 was directed to a computer control unit. Analog voltage, indicative of the smoke concentration in the exposure chamber, was compared to the target voltage, which in turn was related to the desired exposure concentration. If the analog voltage from the RAM-1 was not in agreement with the target voltage, a 2 LPM mass flow controller operating in the vacuum mode (attached at the tee as previously described) altered the amount of smoke from the peristaltic smoke pump available for final dilution and delivery to the chamber.
Physical characterization of smoke aerosol. The particle size distribution was monitored by time of flight analysis using an aerodynamic particle sizer (APS) (model APS33B, TSI, St. Paul, MN). For our experiments, the APS had 48 effective cutoff diameters (ECD) in the particle size range of 0.5-14.9 m and 22 ECD in the size range of 0.5-2.28 m. Calculations of mass median aerodynamic diameter and geometric standard deviation were based on a log-normal distribution.
The exposure concentrations used in this study were 0, 0.4, 0.6, or 0.8 mg WTPM/L. These concentrations were achieved and equilibrated in a bypass exposure system before exposure of mice. During equilibration of the smoke concentration, mice in nose-only restraint tubes were placed on the nose-only exposure system and supplied HEPA-filtered and humidified breathing air. Once a stable concentration was verified, the smoke was directed to the nose-only exposure system.
Animals and Treatment
Six to seven-week-old female A/J mice, purchased from Jackson Laboratory (Bar Harbor, ME), were housed singly and acclimated in an environment providing a 12-h light/dark cycle. The room temperature and humidity were 20 -25°C and 55 Ϯ 15%, respectively. Mice had ad libitum access to water and FIG. 1. Metabolic activation of NNK and related DNA adduct formation. NNK is a procarcinogen in laboratory animals and the activating P 450 enzymes reside mainly in liver and lung. The initial and key step for NNK activation relies on a P 450 -mediated ␣-hydroxylation reaction to the unstable metabolitemethyldiazohydroxide-which donates the methyl group to DNA, forming O 6 MeG. O 6 MeG is recognized as the promutagenic biomarker for NNKinduced tumorigenesis.
pelleted AIN-76A diet (Dyets, Inc., Bethlehem, PA). After acclimation for 14 days, animals were allocated into groups with no statistical differences in group-mean body weights, and the experiment was started.
Effect of cotinine on NNK-induced adducts. To avoid cotinine toxicity, cotinine was administered at 50 mole/mouse in 3 separate doses: 30 min before (25 mole/mouse), immediately after (12.5 mole/mouse), and 30 min after (12.5 mole/mouse) a single intraperitoneal dose of NNK (0, 2.5, 5, 7.5, or 10 mole/mouse). Control animals received physiological saline instead of cotinine. Four hours after NNK treatment, mice were sacrificed by inhalation of 70% CO 2 in air. Lung and liver tissues were collected in sample vials, quick-frozen in liquid nitrogen, and stored at Ϫ70°C until DNA isolation.
Effect of cigarette smoke on NNK-induced adducts. The initial study varied the smoke concentration and kept the NNK dose constant. Mice received nose-only inhalation of CS at 0, 0.4, 0.6, or 0.8 mg WTPM/L for 2 h and NNK (7.5 mole/mouse, ip) was administered at the midpoint of the 2-h exposure. NNK exposure from smoke inhalation ranged from 0 to approximately 18 ng per mouse. Mice were euthanized 4 h after NNK treatment.
In a subsequent study, mice received a one-time, nose-only inhalation regimen of either HEPA-filtered and humidified air (control) or 1R4F CS at a concentration of 0.6 mg WTPM/L for 2 h to monitor the effect of CS on the concentration of O 6 MeG in mice treated with NNK. A single ip dose of NNK (0, 3.75, or 7.5 mole/mouse) was administered to mice at the midpoint of the 2-h exposure. NNK exposure from 0.6 mg WTPM/L for 2 h was approximately 13.5 ng per mouse. Mice were euthanized 4 h after the NNK treatment.
Euthanization and sample collection. Surviving mice were euthanized by inhalation of 70% CO 2 in air. Lung and liver tissues were collected in sample vials, quick-frozen in liquid nitrogen and stored at Ϫ70°C until DNA isolation.
Sample Analysis
Sample preparation. Lung and liver were thawed on ice, weighed and homogenized in 2 ml of ice-chilled Hank's balanced salt solution (HBSS). The DNA was isolated using the Genpure TM 341 Nucleic Acid Purification System (Applied Biosystems, Foster City, CA) and the purified DNA pellet was stored at Ϫ70°C until hydrolyzed. Just prior to hydrolysis, the DNA pellet was dissolved in 230 l of deionized water by incubating the resuspended DNA in an 80°C water bath for 20 min. At the end of the 20-min incubation, 5 l of dissolved DNA was diluted with deionized water (495 l), checked for purity at 260 and 280 nm, and quantified by spectrophotometry at 260 nm. Following determination of the DNA concentration, the remaining DNA solution (0.5-2 mg) was hydrolyzed in 0.1 N HCl for 30 min at 80°C. The hydrolysate was chilled on ice and centrifuged at 10,000 ϫ g for 5 min to remove the pelleted particulates. Hydrolyzed DNA samples were analyzed by HPLC for methylated bases within 16 h of hydrolysis.
Quantification of methylated DNA bases with HPLC. Quantification was conducted as described below using a modification of previous methods (Herron and Shank, 1979; Bedell et al., 1982; Hecht et al., 1986b) . Typical chromatograms using this modified method are illustrated in Figure 2 . For sample analysis, approximately 0.25-1 mg of acid-hydrolyzed DNA sample was injected (Waters 717 Plus Autosampler) into the mobile phase (10% methanol and 90% 50 mM NH 4 H 2 PO 4 , pH 2.0), which was pumped at a flow rate of 1.5 ml/min by a Waters 626 pump assisted by a Waters 600S Controller (Waters Co., Milford, MA). Separation was carried out by two in-line Partisil @ 10-SCX columns (4.6 ϫ 250 mm, 5 m, Whatman, Inc., Clifton, NJ) placed in series. Guanine was detected by a Waters 996 Photodiode Array Detector (absorbance set at 226 nm) and O 6 MeG was detected by a Waters 470 Scanning Fluorescence Detector (using a 16-l flow-through cuvette; excitation :286 nm and emision :366 nm; gain at 1000ϫ; filter at 1.5 nm; window slit at 18 nm). All signals were integrated using Waters Millennium @ Software (Waters Co., Milford, MA). Peak responses were then quantified using calibration curves generated from freshly-prepared Gua and O 6 MeG standards dissolved in 0.1 N HCl. Signals below the limit of detection were interpreted as "0" for statistical analysis.
Authentic standards of guanine and O 6 MeG were prepared fresh in 0.1 N HCl for each batch of HPLC analyses. The mixture was injected 4 times at the beginning of the run and 4 times at the end of the run. The ratios of guanine/O 6 MeG were quantified and variations within each run and among those runs were monitored for reproducibility. Standards were injected and integrated by HPLC for calibration range finding. HPLC precision was determined within each batch run (intra-assay precision) and among batches (interassay) throughout the studies.
Statistics
Two-sample Student's t-test was applied to assess the difference between groups, and the significance level was set at p Ͻ 0.05. A dose-response analysis was performed, comparing the slopes of the NNK effects for mice exposed to cigarette smoke versus mice exposed to filtered air. The dose responses were calculated as the difference of the two orthogonal linear contrasts for the NNK effect. For animals given a fixed amount of NNK, then exposed to varying amounts of cigarette smoke, a comparison was made at each dose level of cigarette smoke to the filtered air-exposed animals with Bonferroni (Krewski and Franklin, 1991) adjustments made for multiple comparisons. For animals that were given varying doses of NNK, a comparison was made between mice exposed to cigarette smoke and mice exposed to filtered air at each NNK dose level (making a Bonferroni adjustment for multiple comparisons). Results were examined to determine if there was a
FIG. 2.
HPLC chromatograms of thermal/acid-hydrolyzed liver DNA from an NNK-treated mouse. Thermal/acid-hydrolzyed DNA sample was quantified using HPLC equipped with two in-line, cation-exchange-based analytical columns. Guanine, the normalizing molecule for quantifying O 6 MeG, was detected by an absorbance detector (lower); O 6 MeG was detected by a fluorescence detector (upper).
dose-response for cigarette smoke, which was calculated from the orthogonal linear contrast involving the cigarette smoke exposures.
The variance was different among the different treatment groups; accordingly, a Satterthwaite approximation was used to determine degrees of freedom for each of the comparisons made.
RESULTS
The instrument calibration range for guanine and O 6 MeG was 0.01-300 nmole and 0.4 -100 pmole, respectively (data not shown). The HPLC precision for the quantification of O 6 MeG was 1.16% (CV) for intra-assays and 4.54% (CV) for inter-assays.
The cotinine treatment regimen (a total of 50 mole/mouse given in 3 separate injections, 30 min before, immediately after, and 30 min after NNK treatment at 5, 7.5 or 10 mole/ mouse) reduced liver concentrations of NNK-induced O 6 MeG up to 35% four hours after NNK injection (Fig. 3) . In the lung, we observed a significant reduction of O 6 MeG at a NNK dose of 7.5 mole/mouse (p Ͻ 0.05) and a trend of reduction is present at the NNK dose of 5.0 mole/mouse, though not statistically significant. Interestingly, at the 10 mole/mouse NNK dose, cotinine showed no effect on the NNK-induced O 6 MeG concentration (Fig. 3) . A/J mice were exposed to cigarette smoke concentrations ranging from 0.4 to 0.8 mg WTPM/L in a 2-h, nose-only regimen. Our studies demonstrate that cigarette smoke exposure alone failed to induce detectable levels of O 6 MeG in A/J mouse lung and liver, consistent with a previous study by Finch et al. (1996) demonstrating that no lung tumors were induced in A/J mice by cigarette smoke. Consistent with previous studies (Peterson and Hecht, 1991) , a single ip injection of NNK (7.5 mole/mouse) produced O 6 MeG DNA adducts in both lung and liver (Figs. 3 and 4) . However, exposure to cigarette smoke reduced the concentration of O 6 MeG in lung and liver in a dose-dependent fashion (Fig. 4) . Due to the high mortality during exposure of mice to 0.8 mg WTPM/L (Table  1) , the exposure level of 0.6 mg WTPM/L, which caused minimal mortality, was recognized as the MTD for the A/J mice in a subsequent 2-h, nose-only 1R4F cigarette smoke inhalation exposure regimen to examine the effect on the NNK response. In this study, O 6 MeG adduct formation in both lung and liver was dependent on the dose of NNK and cigarette smoke was effective in reducing adduct formation in both tissues with a maximal reduction of 46% in lung and 52% in liver (Fig. 5) .
DISCUSSION
Cigarette smoke is a complex mixture consisting of more than 3,500 chemicals including NNK, a tobacco-specific nitro- samine. Studies examining the potential role of NNK in cigarette smoke tumorigenicity are frequently carried out by dosing animals with this nitrosamine to demonstrate tumorigenicity in target organs (Hecht et al., 1989) . These studies are generally conducted by injecting rodents with 5 to 10 moles of NNK. The amount of NNK in a Kentucky reference 1R4F cigarette, which is designed to represent the U.S. market, is 67 ng/ cigarette (Borgerding et al., 1997) . Therefore, the amount of NNK used to demonstrate carcinogenicity in A/J mice is equivalent to the amount of NNK extracted from the mainstream smoke of 15,000 to 30,000 cigarettes. Although highly exaggerated doses are often used in rodent carcinogenicity studies, the NNK carcinogenicity studies could be criticized in that the experimental design employed fails to account for the inhibitory or stimulatory effect(s) of other chemicals in the tobacco smoke mixture on the carcinogenicity of NNK. Hence, it is more appropriate that the role of NNK in the toxicity and/or potential carcinogenicity of tobacco smoke be evaluated in a test system concurrently dosed with cigarette smoke, or at least some of its components.
Metabolism of nicotine to cotinine in vivo occurs within minutes after nicotine absorption, with cotinine having a halflife of 19 -24 h in rodents (Rama Sastry et al., 1995) . Hence, nicotine absorbed internally from cigarette smoke is rapidly converted to cotinine, which then resides within the body for a much longer period than nicotine. The current study demonstrates that cotinine significantly reduces the number of O 6 MeG DNA adducts produced by injected NNK. Previous studies have shown that ␣-hydroxylation of NNK is catalyzed mainly by cytochromes P 450 (Hecht, 1996) . In mouse lung, CYP2A1 and CYP2B1 appear to be the cytochromes P 450 that act as catalysis of ␣-hydroxylation. In the mouse liver, CYP1A2, CYP2A6, and CYP2E1 play prominent roles (Hecht, 1996) . We hypothesize that the reduction of O 6 MeG in liver and lung is due to competitive inhibition by cotinine of the cytochrome P 450 enzyme system for NNK activation. In ciga- Note. Mice were exposed nose-only to cigarette smoke for 2 h. NNK was administered to the mice at the midpoint of the 2-h exposure. Mortality of the mice was determined 4 h after NNK treatment (n ϭ 18). rette smoke, the ratio of nicotine to NNK has been reported to vary between 3,000:1 and 30,000:1 (Richter and Tricker, 1994) . In the present study, the mass ratio between cotinine and NNK is limited, due to a necessity to deliver a sufficiently large dose of NNK to generate amounts of O 6 MeG detectable through HPLC, while at the same time keeping the cotinine below toxic levels. Our results indicate that cotinine, at a mass ratio to NNK as low as 5:1, significantly (p Ͻ 0.05) reduces the concentration of O 6 MeG produced by NNK in A/J mouse liver, and ratios as low as 6.67:1 significantly (p Ͻ 0.05) reduces the concentration of O 6 MeG produced by NNK in A/J mouse lung. This reduction might be much greater within the situation of real smoke, given that the cotinine/NNK ratio in cigarette smoke is approximately 500 times higher than the ratios we used in this study. This hypothesis is supported by our observation that O 6 MeG adducts were not detected in mice acutely exposed to a maximum tolerated dose (MTD) of cigarette smoke. This data is consistent with tumorigenesis results previously reported by Finch et al. (1996) . Those studies demonstrated that no lung tumors were induced or promoted in A/J mice by cigarette smoke at a concentration of 248 mg total particulate matter/m 3 for 6 h/day, 5 days/week, for 26 weeks. In our studies, cigarette smoke exposure concurrent with ip NNK administration significantly reduced the formation of O 6 MeG in a dose-dependent fashion, with a maximum reduction of 46% and 52% in lung and liver, respectively. These results are consistent with the results of Hecht et al. (1983) , which indicated that exposure to cigarette smoke increased the survival rate in NNK-treated rodents compared to controls exposed to air. This study demonstrates for the first time that cotinine, the major metabolite of nicotine, as well as cigarette smoke effectively reduce the level of promutagenic DNA adducts induced by NNK. This study provides a mechanistic basis for previous dichotomous observations that NNK, but not tobacco smoke, induces lung adenomas in the A/J mouse.
